Redcare Pharmacy NV (RDC.DE)

EUR 139.9

(-3.38%)

EBITDA Summary of Redcare Pharmacy NV

  • Redcare Pharmacy NV's latest annual EBITDA in 2023 was 58.17 Million EUR , up 222.01% from previous year.
  • Redcare Pharmacy NV's latest quarterly EBITDA in 2024 Q1 was 10.55 Million EUR , up 144.19% from previous quarter.
  • Redcare Pharmacy NV reported an annual EBITDA of -30.64 Million EUR in 2022, down -66.94% from previous year.
  • Redcare Pharmacy NV reported an annual EBITDA of -37.41 Million EUR in 2021, down -281.91% from previous year.
  • Redcare Pharmacy NV reported a quarterly EBITDA of 13.88 Million EUR for 2024 Q2, up 31.27% from previous quarter.
  • Redcare Pharmacy NV reported a quarterly EBITDA of 5.34 Million EUR for 2023 Q1, up 157.65% from previous quarter.

Annual EBITDA Chart of Redcare Pharmacy NV (2023 - 2013)

Historical Annual EBITDA of Redcare Pharmacy NV (2023 - 2013)

Year EBITDA EBITDA Growth
2023 58.17 Million EUR 222.01%
2022 -30.64 Million EUR -66.94%
2021 -37.41 Million EUR -281.91%
2020 14.65 Million EUR 153.56%
2019 -19.83 Million EUR -34.12%
2018 -16.32 Million EUR -25.92%
2017 -12.09 Million EUR -44.9%
2016 -8.35 Million EUR -37.77%
2015 -6.06 Million EUR -153.34%
2014 -2.39 Million EUR -218.09%
2013 -752 Thousand EUR 0.0%

Peer EBITDA Comparison of Redcare Pharmacy NV

Name EBITDA EBITDA Difference
Newron Pharmaceuticals S.p.A. -11.71 Million EUR 596.387%